196 related articles for article (PubMed ID: 10871404)
1. HMG I/Y regulates long-range enhancer-dependent transcription on DNA and chromatin by changes in DNA topology.
Bagga R; Michalowski S; Sabnis R; Griffith JD; Emerson BM
Nucleic Acids Res; 2000 Jul; 28(13):2541-50. PubMed ID: 10871404
[TBL] [Abstract][Full Text] [Related]
2. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.
Yie J; Merika M; Munshi N; Chen G; Thanos D
EMBO J; 1999 Jun; 18(11):3074-89. PubMed ID: 10357819
[TBL] [Abstract][Full Text] [Related]
3. An HMG I/Y-containing repressor complex and supercoiled DNA topology are critical for long-range enhancer-dependent transcription in vitro.
Bagga R; Emerson BM
Genes Dev; 1997 Mar; 11(5):629-39. PubMed ID: 9119227
[TBL] [Abstract][Full Text] [Related]
4. PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms.
Lewis RT; Andreucci A; Nikolajczyk BS
J Biol Chem; 2001 Mar; 276(12):9550-7. PubMed ID: 11124259
[TBL] [Abstract][Full Text] [Related]
5. Binding of HMG-I(Y) imparts architectural specificity to a positioned nucleosome on the promoter of the human interleukin-2 receptor alpha gene.
Reeves R; Leonard WJ; Nissen MS
Mol Cell Biol; 2000 Jul; 20(13):4666-79. PubMed ID: 10848593
[TBL] [Abstract][Full Text] [Related]
6. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter.
Yie J; Liang S; Merika M; Thanos D
Mol Cell Biol; 1997 Jul; 17(7):3649-62. PubMed ID: 9199299
[TBL] [Abstract][Full Text] [Related]
7. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
[TBL] [Abstract][Full Text] [Related]
8. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
Ward SB; Hernandez-Hoyos G; Chen F; Waterman M; Reeves R; Rothenberg EV
Nucleic Acids Res; 1998 Jun; 26(12):2923-34. PubMed ID: 9611237
[TBL] [Abstract][Full Text] [Related]
9. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1.
Hill DA; Pedulla ML; Reeves R
Nucleic Acids Res; 1999 May; 27(10):2135-44. PubMed ID: 10219086
[TBL] [Abstract][Full Text] [Related]
10. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
11. HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.
Bouallaga I; Teissier S; Yaniv M; Thierry F
Mol Cell Biol; 2003 Apr; 23(7):2329-40. PubMed ID: 12640118
[TBL] [Abstract][Full Text] [Related]
12. Enhancer activity of HS2 of the human beta-LCR is modulated by distance from the key nucleosome.
Onishi Y; Kiyama R
Nucleic Acids Res; 2001 Aug; 29(16):3448-57. PubMed ID: 11504883
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.
Munshi N; Merika M; Yie J; Senger K; Chen G; Thanos D
Mol Cell; 1998 Oct; 2(4):457-67. PubMed ID: 9809067
[TBL] [Abstract][Full Text] [Related]
14. An HMG-like protein that can switch a transcriptional activator to a repressor.
Lehming N; Thanos D; Brickman JM; Ma J; Maniatis T; Ptashne M
Nature; 1994 Sep; 371(6493):175-9. PubMed ID: 8072548
[TBL] [Abstract][Full Text] [Related]
15. The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression.
Chau KY; Munshi N; Keane-Myers A; Cheung-Chau KW; Tai AK; Manfioletti G; Dorey CK; Thanos D; Zack DJ; Ono SJ
J Neurosci; 2000 Oct; 20(19):7317-24. PubMed ID: 11007889
[TBL] [Abstract][Full Text] [Related]
16. Binding of HMG-I(Y) elicits structural changes in a silencer of the human beta-globin gene.
Chase MB; Haga SB; Hankins WD; Williams DM; Bi Z; Strovel JW; Obriecht C; Berg PE
Am J Hematol; 1999 Jan; 60(1):27-35. PubMed ID: 9883803
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.
McDowell JC; Dean A
Mol Cell Biol; 1999 Nov; 19(11):7600-9. PubMed ID: 10523648
[TBL] [Abstract][Full Text] [Related]
18. Promoter structure and transcriptional activation with chromatin templates assembled in vitro. A single Gal4-VP16 dimer binds to chromatin or to DNA with comparable affinity.
Pazin MJ; Hermann JW; Kadonaga JT
J Biol Chem; 1998 Dec; 273(51):34653-60. PubMed ID: 9852139
[TBL] [Abstract][Full Text] [Related]
19. The long terminal repeat (LTR) of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2.
Yu X; Zhu X; Pi W; Ling J; Ko L; Takeda Y; Tuan D
J Biol Chem; 2005 Oct; 280(42):35184-94. PubMed ID: 16105833
[TBL] [Abstract][Full Text] [Related]
20. Interactions between proteins bound to the duck beta A-globin gene promoter and enhancer detected by the DNaseI footprinting.
Cvekl A; Paces V
Gene; 1992 Jan; 110(2):225-8. PubMed ID: 1537559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
